Episode 1328 • • 50:19 - 54:32
1328: White Adjacent
Molnupiravir and the Shift to COVID-19 Antiviral Pills
A new oral antiviral drug called Molnupiravir is being positioned as a "Tamiflu for COVID," with early Phase 2 data showing it clears the virus in five days. Dr. Fauci and other researchers suggest that oral drugs are necessary to suppress the virus, similar to treatments for HIV and Hepatitis C. Critics argue that existing, cheaper alternatives like Ivermectin are being ignored in favor of expensive new pharmaceutical products like "COVID-27" preparations.